文献速递眼底病与葡萄膜炎

非增殖型2型黄斑毛细血管扩张症中进展性内层视网膜神经退行性变

Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2.
PubMed 文献 · Br J Ophthalmol · 2025-02-24

这项回顾性多中心比较病例系列纳入115例非增殖型2型黄斑毛细血管扩张症(MacTel)患者,其中50%合并糖尿病、18%有碳酸酐酶抑制剂(CAI)治疗史。OCT分层分析显示,无糖尿病且未用CAI者颞侧旁中心凹神经纤维层以每年-0.25±0.09 µm速率变薄;CAI治疗眼GCL变薄速率快于未治疗眼;合并与不合并糖尿病的MacTel患者变薄速率相似。作者结论为MacTel存在进展性内层视网膜神经退行性变,需进一步研究其后果。

要点

  • MacTel患者内层视网膜(GCL与NFL)厚度随时间进展性变薄。
  • 无糖尿病未用CAI者颞侧旁中心凹NFL每年变薄-0.25±0.09 µm。
  • CAI治疗眼GCL变薄速率快于未治疗眼(-1.23±0.21 vs -0.19±0.16 µm/年)。

核心结论

  • MacTel患者存在进展性内层视网膜神经退行性变,速率与无糖尿病视网膜病变的糖尿病患者相似。
  • 作者指出需进一步研究以理解MacTel中视网膜变薄的后果。

研究设计与样本

  • 回顾性、多中心、比较病例系列,纳入至少两次OCT检查间隔大于9个月的MacTel患者,共115例。
  • 57例(50%)合并糖尿病,21例(18%)有碳酸酐酶抑制剂(CAI)治疗史。
  • 采用Iowa参考算法对OCT进行分层,计算早期治疗糖尿病视网膜病变研究网格总面积及内颞侧区域的NFL与GCL平均厚度。
  • 使用混合效应模型分析各亚层及各区域视网膜厚度随时间的变化率。

主要发现

  • 合并与不合并糖尿病的MacTel患者视网膜变薄速率相似。
  • 无糖尿病且未用CAI的患者,颞侧旁中心凹NFL变薄速率为-0.25±0.09 µm/年(95%CI [-0.42至-0.09];p=0.003)。
  • CAI治疗眼亚区4的GCL变薄速率为-1.23±0.21 µm/年(95%CI [-1.64至-0.82]),未治疗眼为-0.19±0.16 µm/年(95%CI [-0.50至0.11]),p<0.001,内核层亦见类似效应。
  • 观察到进展性外层视网膜变薄。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性,但作者在结论中指出需进一步研究以理解MacTel中视网膜变薄的后果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Patients with non-proliferative macular telangiectasia type 2 (MacTel) have ganglion cell layer (GCL) and nerve fibre layer (NFL) loss, but it is unclear whether the thinning is progressive. We quantified the change in retinal layer thickness over time in MacTel with and without diabetes. METHODS: In this retrospective, multicentre, comparative case series, subjects with MacTel with at least two optical coherence tomographic (OCT) scans separated by >9 months OCTs were segmented using the Iowa Reference Algorithms. Mean NFL and GCL thickness was computed across the total area of the early treatment diabetic retinopathy study grid and for the inner temporal region to determine the rate of thinning over time. Mixed effects models were fit to each layer and region to determine retinal thinning for each sublayer over time. RESULTS: 115 patients with MacTel were included; 57 patients (50%) had diabetes and 21 (18%) had a history of carbonic anhydrase inhibitor (CAI) treatment. MacTel patients with and without diabetes had similar rates of thinning. In patients without diabetes and untreated with CAIs, the temporal parafoveal NFL thinned at a rate of -0.25±0.09 µm/year (95% CI [-0.42 to -0.09]; p=0.003). The GCL in subfield 4 thinned faster in the eyes treated with CAI (-1.23±0.21 µm/year; 95% CI [-1.64 to -0.82]) than in untreated eyes (-0.19±0.16; 95% CI [-0.50, 0.11]; p<0.001), an effect also seen for the inner nuclear layer. Progressive outer retinal thinning was observed. CONCLUSIONS: Patients with MacTel sustain progressive inner retinal neurodegeneration similar to those with diabetes without diabetic retinopathy. Further research is needed to understand the consequences of retinal thinning in MacTel.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Amram AL, Whitmore SS, Wang C, et al. Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2. Br J Ophthalmol. 2025. PMID: 39288977. doi:10.1136/bjo-2023-325115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。